Literature DB >> 9352505

Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants.

S G Novick1, J C Godfrey, R L Pollack, H R Wilder.   

Abstract

Free ionic zinc (Zn2+) in saliva shortens duration and severity of common cold (CC) symptoms. It is proposed that Zn2+ complexes with proteins of critical nerve endings and surface proteins of human rhinovirus (HRV) (a) interrupt nerve impulses and (b) block docking of HRV on intercellular adhesion molecule-1 (ICAM-1) on somatic cells, thereby interrupting HRV infection. Since leukocyte function associated antigen-1 (LFA-1) binds leukocytes to cells through ICAM-1, initiating inflammation, Zn2+ is expected to block LFA-1/ICAM-1 binding and thereby suppress inflammation. This could explain reduction of inflammation experienced by persons taking zinc gluconate/glycine (ZGG) lozenges for CC. Allergic rhinitis (AR) and CC share many common symptoms, and ZGG also mitigates AR symptoms. Focal irritation, increased ICAM-1 expression, and recruitment of leukocytes to epithelial foci are the common elements. Zinc ions may be an important anti-inflammatory factor because they can block docking of both HRV and LFA-1 with ICAM-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352505     DOI: 10.1016/s0306-9877(97)90201-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

1.  Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.

Authors:  Hideyuki Suzuki; Ken Sato; Hitoshi Takagi; Daisuke Kanda; Naondo Sohara; Satoru Kakizaki; Hiroaki Nakajima; Toshiyuki Otsuka; Takeaki Nagamine; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

2.  Differential effects of zinc in severe pneumonia in children.

Authors:  Rashmi Ranjan Das
Journal:  Indian J Pediatr       Date:  2011-05-12       Impact factor: 1.967

3.  Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C.

Authors:  Ke Ih Kim; Soo Ryang Kim; Noriko Sasase; Yoko Akimoto; Mao Shikata; Aya Ohtani; Teruko Hirooka; Kazuhiko Tanaka
Journal:  Hepatol Int       Date:  2008-01-11       Impact factor: 6.047

4.  Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.

Authors:  Hideyuki Suzuki; Hitoshi Takagi; Naondo Sohara; Daisuke Kanda; Satoru Kakizaki; Ken Sato; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  Zinc sulfate inhibited inflammation of Der p2-induced airway smooth muscle cells by suppressing ERK1/2 and NF-κB phosphorylation.

Authors:  Chia-Ju Shih; Ya-Ling Chiou
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

6.  Extracellular zinc and ATP-gated P2X receptor calcium entry channels: New zinc receptors as physiological sensors and therapeutic targets.

Authors:  Erik M Schwiebert; Lihua Liang; Nai-Lin Cheng; Clintoria Richards Williams; Dragos Olteanu; Elisabeth A Welty; Akos Zsembery
Journal:  Purinergic Signal       Date:  2005-12-03       Impact factor: 3.765

Review 7.  Efficacy of zinc against common cold viruses: an overview.

Authors:  Darrell Hulisz
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Sep-Oct

Review 8.  The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.

Authors:  Inga Wessels; Benjamin Rolles; Lothar Rink
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

9.  Potential role of zinc supplementation in prophylaxis and treatment of COVID-19.

Authors:  Amit Kumar; Yuichi Kubota; Mikhail Chernov; Hidetoshi Kasuya
Journal:  Med Hypotheses       Date:  2020-05-25       Impact factor: 1.538

10.  On the Efficacy of ZnO Nanostructures against SARS-CoV-2.

Authors:  Maria Chiara Sportelli; Margherita Izzi; Daniela Loconsole; Anna Sallustio; Rosaria Anna Picca; Roberto Felici; Maria Chironna; Nicola Cioffi
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.